Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to stretch out money

.Turnstone Biologics is reducing its head count by 60% and also shocking its C-suite to always keep ...

Gilead surrenders on $15M MASH wager after weighing preclinical information

.In a year that has actually viewed an authorization and also a plethora of readouts for metabolic d...

Texas biotech axes cancer cells contract, pins wishes on weight problems

.Alaunos Therapies is axing an arrangement with Precigen, quiting licensing civil liberties to an in...

Capricor allotments more data for DMD treatment after triggering BLA

.Capricor Rehabs is taking a success tour for their period 2 Duchenne muscular dystrophy (DMD) trial...

FDA spots Kezar lupus test in grip complying with 4 patient fatalities

.The FDA has actually placed Kezar Lifestyle Sciences' lupus test on grip after the biotech warned f...

Phase 3 Intellectual Rock test attacks SMA objective, delivering stock up 200%

.A phase 3 trial of Intellectual Rock's spinal muscle atrophy (SMA) candidate has reached its own ma...

CAMP 4 is latest to eye IPO, while Upstream point out $182M plan

.RNA biotech CAMP4 Therapies has marked out plans for a $67 million IPO, along with inflammation-foc...

Galecto gets leukemia drug, drops bone tissue cancer cells property in pivot

.A year after the failing of an idiopathic lung fibrosis applicant sent Galecto on a search for rede...

Judo tosses down $100M to knock senseless renal disease

.Taking the mat is actually Judo Bio, an up-and-coming biotech armed along with $one hundred thousan...

AstraZeneca pays CSPC $100M for preclinical heart problem medication

.AstraZeneca has actually settled CSPC Drug Team $100 million for a preclinical heart attack drug. T...